Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.6, 2007-01, pp. : 453-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monophasic Estrogen-Progestogen Therapy and Sexuality in Postmenopausal Women

By Fonseca A.M. Bagnoli V.R. Penteado S.R.L. Paixão J.S. Cavalcanti A.L. Pinotti J.A.

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 131-137

Adis International

Access to resources Recommend Favorite

Estradiol/drospirenone: BP-lowering effect in postmenopausal women

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Hormone replacement therapy (HRT) with drospirenone offers the additional benefit of blood pressure reduction in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 2, 2008-02 ,pp. : 12-14

Adis International

Access to resources Recommend Favorite

Estradiol/drospirenone improves postmenopausal symptoms

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

New Progestogens: A Review of Their Effects in Perimenopausal and Postmenopausal Women

By Régine Sitruk-Ware

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 865-883

Adis International

Access to resources Recommend Favorite